These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
637 related articles for article (PubMed ID: 21642833)
1. Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Culos KA; Cannon JP; Grim SA Am J Ther; 2013; 20(2):200-12. PubMed ID: 21642833 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Segarra-Newnham M; Church TJ Ann Pharmacother; 2012 Dec; 46(12):1678-87. PubMed ID: 23232021 [TBL] [Abstract][Full Text] [Related]
3. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Micek ST Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus. Maclayton DO; Hall RG Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012 [TBL] [Abstract][Full Text] [Related]
5. Treatment of infections due to resistant Staphylococcus aureus. Anstead GM; Cadena J; Javeri H Methods Mol Biol; 2014; 1085():259-309. PubMed ID: 24085702 [TBL] [Abstract][Full Text] [Related]
6. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents. Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935 [TBL] [Abstract][Full Text] [Related]
7. Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care. Tverdek FP; Crank CW; Segreti J Crit Care Clin; 2008 Apr; 24(2):249-60, vii-viii. PubMed ID: 18361944 [TBL] [Abstract][Full Text] [Related]
9. Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond. Holmes NE; Tong SY; Davis JS; van Hal SJ Semin Respir Crit Care Med; 2015 Feb; 36(1):17-30. PubMed ID: 25643268 [TBL] [Abstract][Full Text] [Related]
10. Can clinical and molecular epidemiologic parameters guide empiric treatment with vancomycin for methicillin-resistant Staphylococcus aureus infections? Yamaki J; Lee M; Shriner KA; Wong-Beringer A Diagn Microbiol Infect Dis; 2011 May; 70(1):124-30. PubMed ID: 21392923 [TBL] [Abstract][Full Text] [Related]
11. Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin. Marconescu P; Graviss EA; Musher DM Scand J Infect Dis; 2012 Aug; 44(8):620-2. PubMed ID: 22668202 [TBL] [Abstract][Full Text] [Related]
12. Treatment of infections caused by resistant Staphylococcus aureus. Anstead GM; Quinones-Nazario G; Lewis JS Methods Mol Biol; 2007; 391():227-58. PubMed ID: 18025681 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC. Kao TM; Wang JT; Weng CM; Chen YC; Chang SC J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980 [TBL] [Abstract][Full Text] [Related]
14. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Moore CL; Osaki-Kiyan P; Haque NZ; Perri MB; Donabedian S; Zervos MJ Clin Infect Dis; 2012 Jan; 54(1):51-8. PubMed ID: 22109947 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options. Welte T; Pletz MW Int J Antimicrob Agents; 2010 Nov; 36(5):391-400. PubMed ID: 20724119 [TBL] [Abstract][Full Text] [Related]
16. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE; Wells EM Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750 [TBL] [Abstract][Full Text] [Related]